Endpoint News Merck makes first big splash for Alzheimer's drug R&D since 2017 fail, inking research pact with Cerevance
Cambridge Independent Cerevance adapts Cambridge Science Park office to safeguard against Covid-19 with help from COEL
Pharmaceutical Technology Breakthrough in neurodegeneration: GV, Bill Gates and Foresite invest $45M in Cerevance
Fierce Biotech Cerevance gains a new drug discovery chief as another AstraZeneca executive jumps ship
BioCentury Cerevance’s human element: HOW CEREVANCE’S PLATFORM IDENTIFIES CIRCUIT-SPECIFIC CNS TARGETS
The Rockefeller University New method for studying gene expression could improve understanding of brain disease